©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 21, 2015; 21(43): 12311-12321
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12311
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12311
Role of liver transplantation in human immunodeficiency virus positive patients
Deepak Joshi, Kosh Agarwal, Institute of Liver Studies, King’s College Hospital NHS Foundation Trust, Denmark Hill, SE5 9RS London, United Kingdom
Author contributions: Joshi D and Agarwal K reviewed the literature and wrote the manuscript.
Conflict-of-interest statement: The authors have no conflicts of interest to report.
Correspondence to: Dr. Deepak Joshi, Institute of Liver Studies, King’s College Hospital NHS Foundation Trust, Denmark Hill, SE5 9RS London, United Kingdom. d.joshi@nhs.net
Telephone: +44-203-2999000
Received: April 24, 2015
Peer-review started: April 24, 2015
First decision: August 2, 2015
Revised: August 4, 2015
Accepted: October 23, 2015
Article in press: October 26, 2015
Published online: November 21, 2015
Processing time: 208 Days and 8.5 Hours
Peer-review started: April 24, 2015
First decision: August 2, 2015
Revised: August 4, 2015
Accepted: October 23, 2015
Article in press: October 26, 2015
Published online: November 21, 2015
Processing time: 208 Days and 8.5 Hours
Core Tip
Core tip: Liver disease is a major cause of mortality and morbidity in human immunodeficiency virus (HIV) positive patients. It is therefore increasingly likely that HIV positive patients with chronic liver disease are likely to present as potential liver transplant candidates. We therefore review the current data with regards to liver transplantation in HIV positive patients.